C82.40
Follicular lymphoma grade IIIb, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Follicular lymphoma grade IIIb is a type of blood cancer that originates in the lymphatic system, specifically affecting a subtype of white blood cells called lymphocytes. Classified under the ICD-10 code C82.40, this lymphoma falls into the category of non-Hodgkin lymphomas. It is characterized by its aggressive behavior and distinctive appearance under the microscope, involving large, transformed lymphocytes that form follicle-like structures. This form of lymphoma can appear in various parts of the body and requires careful medical evaluation for appropriate treatment planning.
Causes & Symptoms
Clinical Causes: Genetic mutations within lymphocytes that lead to abnormal cell growth Certain infections, such as human immunodeficiency virus (HIV) and Epstein-Barr virus (EBV), which may increase risk Environmental exposures to chemicals or radiation, although direct links are still being studied A family history of lymphoma or other hematological cancers
Key Symptoms: Swollen lymph nodes that are usually painless and may be felt in the neck, armpits, or groin Unexplained weight loss Persistent fatigue or weakness Fever and night sweats, often referred to as B symptoms Loss of appetite Itching skin in some cases Potential abdominal discomfort if lymph nodes in the abdomen are involved
Diagnostic & Treatment
Diagnosis Path: Diagnosing follicular lymphoma grade IIIb involves a combination of physical examinations, blood tests, imaging studies, and tissue biopsies. The process includes: - Physical exam to locate swollen lymph nodes - Blood tests to evaluate overall health and detect markers associated with lymphoma - Imaging tests such as CT scans or PET scans to identify the extent of disease - A lymph node biopsy, where a small sample tissue is surgically removed and examined microscopically to confirm the presence of grade IIIb follicular lymphoma and assess its characteristics - Additional pathological analysis to determine the specific grade and other molecular features that can influence treatment options
Treatment Protocols: Treatment strategies for follicular lymphoma grade IIIb are tailored to the individual and often involve a multidisciplinary approach. Common options include: - Chemotherapy, often combined with immunotherapy agents like rituximab to target specific B-cells - Targeted therapy drugs that act on specific molecules involved in the growth of lymphoma cells - Radiation therapy to control localized disease in certain cases - Stem cell transplantation, considered for advanced or refractory cases - Clinical trials exploring new and emerging therapies The choice of treatment depends on factors such as the stage of the disease, patient's overall health, and specific characteristics of the lymphoma. Regular follow-up with medical professionals is essential to monitor the response to therapy and manage any side effects or complications.
Clinical Advice & FAQs
Billing Guidance
Is C82.40 a billable ICD-10 code?
Yes, C82.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C82.40?
Clinical documentation must specify the nature of Follicular lymphoma grade IIIb, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference